Neoadjuvant cisplatin fails to beat standard AC in HER2-negative breast cancerDecember 20, 2019Breast Cancer
Chemotherapy better for metastatic breast cancer maintenance than durvalumabDecember 20, 2019Breast Cancer
FDA approves antibody-drug conjugate for advanced urothelial cancerDecember 19, 2019Genitourinary Cancer
RCC: Tivozanib beats sorafenib in later linesDecember 19, 2019Renal Cell CarcinomaGenitourinary Cancer
Oral paclitaxel bests IV version for tumor response, neuropathy incidence in mBCDecember 19, 2019Breast Cancer
Platinum-based therapy superior in study of upper GI tumorsDecember 18, 2019GastroenterologyGastrointestinal Cancer
New guideline provides recommendations for radiation therapy of basal cell, squamous cell cancersDecember 18, 2019Nonmelanoma Skin Cancer
D-RVd for frontline myeloma looks robust in GRIFFIN trial updateDecember 17, 2019Lymphoma & Plasma Cell Disorders
First report from NeoTRIPaPDL1: No pCR benefit with atezolizumab in TNBCDecember 16, 2019Breast Cancer
